This federal contract award is for the delivery of pharmaceutical products, including the HIV treatment medication Biktarvy, to support military and government healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $94,776.72, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 29, 2024.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 11:05 AM